These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin. Starenki DV, Namba H, Saenko VA, Ohtsuru A, Maeda S, Umezawa K, Yamashita S. Clin Cancer Res; 2004 Oct 15; 10(20):6821-9. PubMed ID: 15501958 [Abstract] [Full Text] [Related]
6. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Lampiasi N, Azzolina A, D'Alessandro N, Umezawa K, McCubrey JA, Montalto G, Cervello M. Mol Pharmacol; 2009 Aug 15; 76(2):290-300. PubMed ID: 19461054 [Abstract] [Full Text] [Related]
7. Imatinib enhances docetaxel-induced apoptosis through inhibition of nuclear factor-κB activation in anaplastic thyroid carcinoma cells. Kim E, Matsuse M, Saenko V, Suzuki K, Ohtsuru A, Mitsutake N, Yamashita S. Thyroid; 2012 Jul 15; 22(7):717-24. PubMed ID: 22650230 [Abstract] [Full Text] [Related]
13. Combined inhibition of NF-κB and Bcl-2 triggers synergistic reduction of viability and induces apoptosis in melanoma cells. Watanabe M, Umezawa K, Higashihara M, Horie R. Oncol Res; 2013 Jul 15; 21(4):173-80. PubMed ID: 24762223 [Abstract] [Full Text] [Related]